AndersonJ. E.; McIntoshL. M.; PoettickerR.Deflazacort but not prednisone improves both muscle repair and fiber growth in diaphragm and limb muscle in vivo in the mdx dystrophic mouse.Muscle Nerve19: 1576–1585; 1996.
4.
AndersonJ. E.; WeberM.; VargasC.Deflazacort increases laminin expression and myogenic repair, and induces early persistent functional gain in mdx mouse muscular dystrophy.Cell Transplant.9: 551–564; 2000.
5.
BeauchampJ.; MorganJ.; PagelC.; PartridgeT.Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source.J. Cell Biol.144: 1113–1122; 1999.
6.
BeauchampJ. R.; MorganJ. E.; PagelC. N.; PartridgeT. A.Quantitative studies of the efficacy of myoblast transplantation.Muscle Nerve Suppl.4: S261; 1994.
7.
BeinerJ. M.; JoklP.; CholewickiJ.; PanjabiM. M.The effect of anabolic steroids and corticosteroids on healing of muscle contusion injury.Am. J. Sports Med.27: 2–9; 1999.
8.
FanY.; MaleyM.; BeilharzM.; GroundsM.Rapid death of injected myoblasts in myoblast transfer therapy.Muscle Nerve19: 853–860; 1996.
9.
FerrariG.; Cusella-De AngelisG.; ColettaM.; PaolucciE.; StornaiuoloA.; CossuG.; MavilioF.Muscle regeneration by bone marrow-derived myogenic progenitors.Science279: 1528–1530; 1998.
10.
GoldringK.; JonesG. E.; WattD. J.A factor implicated in the myogenic conversion of nonmuscle cells derived from the mouse dermis.Cell Transplant.9: 519–529; 2000.
11.
GroundsM. D.Editorial: Satellite cells and myoblast transfer therapy.Basic Appl. Myol.7: 160; 1997.
GussoniE.; SoneokaY.; StricklandC. D.; BuzneyE. A.; KhanM. K.; FlintA. F.; KunkelL. M.; MulliganR. C.Dystrophin expression in the mdx mouse restored by stem cell transplantation.Nature401: 390–394; 1999.
14.
HayesA.; WilliamsD. A.Examining potential drug therapies for muscular dystrophy utilising the dy/dy mouse I: Clenbuterol.J. Neurol. Sci.157: 122–128; 1998.
15.
HodgettsS. I.; BeilharzM. W.; ScalzoA. A.; GroundsM. D.Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or NK1.1+ cells.Cell Transplant.9: 489–502; 2000.
16.
HuardJ.; RoyR.; GueretteB.; VerreaultS.; TremblayG.; TremblayJ. P.Human myoblast transplantation in immunodeficient and immunosuppressed mice: Evidence of rejection.Muscle Nerve17: 224–234; 1994.
17.
IrintchevA.; LangerM.; ZweyerM.; WernigA.Myoblast transplantation in the mouse: What cells do we use?Basic Appl. Myol.7: 161–166; 1997.
18.
JacksonK.; MiT.; GoodellM.Hematopoietic potential of stem cells isolated from murine skeletal muscle.Proc. Natl. Acad. Sci. USA96: 14482–14486; 1999.
19.
McIntoshL.; GranbergK. E.; BriereK. M.; AndersonJ. E.Nuclear magnetic resonance spectroscopy study of muscle growth, mdx dystrophy and glucocorticoid treatments: Correlation with repair.NMR Biomed.11: 1–10; 1998.
20.
PagelC. N.; MorganJ. E.; GrossJ. G.; PartridgeT. A.Thymic myoid cells as a source of cells for myoblast transfer.Cell Transplant.9: 531–538; 2000.
21.
PartridgeT.The ‘fantastic voyage’ of muscle progenitor cells.Nat. Med.4: 554–555; 1998.
22.
PetersenZ. Q.; HuardJ.The influence of muscle fiber type in myoblast-mediated gene transfer to skeletal muscle.Cell Transplant.9: 503–517; 2000.
23.
SmytheG. M.; FanY.; GroundsM. D.Enhanced donor myoblast migration and fusion in normal and dystrophic host muscle.Muscle Nerve23(4): 560–574; 2000.
24.
SmytheG. M.; GroundsM. D.Exposure to tissue culture conditions can adversely affect myoblast behavior in vivo in whole muscle grafts: Implications for myoblast transfer therapy.Cell Transplant.9: 379–393; 2000.
25.
TorrenteY.; El FahimeE.; CaronN. J.; BresolinN.; TremblayJ. P.Intramuscular migration of myoblasts transplanted after muscle pretreatment with metalloproteinases.Cell Transplant.9: 539–549; 2000.
26.
TremblayJ.; GueretteB.Myoblast transplantation: A brief review of the problems and some solutions.Basic Appl. Myol.7: 221–230; 1997.
27.
WattD. J.; KarasinskiJ.; MossJ.Migration of muscle cells.Nature386: 406–407; 1994.